Ahead of their graduation earlier this month, two Lake Forest High School students received national recognition for the ...

U.S. pharmaceutical firms are ramping up licensing deals with Chinese biotech companies, aiming to fill pipelines as major drug patents near expiration.

During the Covid-19 pandemic, South African and Colombian civil society organisations initiated strategic litigation against ...

Discover how U.S. biotechs can learn from China's success in affordable, high-quality drug development. Read more here.

Residents living near Port of Cork are in for a surprise this Friday, as a loud warning siren is set to blare across ...

After months of waking up with headaches, Claire visited her GP. Her life was turned upside down as doctors discovered what ...

The sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...

Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...

US drugmakers are betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

The president wants foreign countries to pay more for drugs made in the US to help Big Pharma firms make more money abroad.